Mohamed Elrayess is the section head of basic research in Qatar University’s Health Sector. He received his Ph.D. in cardiovascular genetics from University College London, United Kingdom, in 2003. He worked as a postdoctoral fellow in the cardiovascular medicine unit at University College London (2003–2004) and as a scientist at Eisai (2004–2012), a top international pharmaceutical company, where he developed skills in drug discovery and development, mainly focusing on stem cell therapy. He then spent the following seven years (2012–2019) working as a senior scientist at Anti-Doping Lab Qatar, an international testing laboratory for doping abuse by elite athletes, using various OMICS approaches for the identification of the novel biomarkers of insulin resistance and diabetes and the investigation of the genetics and metabolomics of elite athletes. He joined Qatar University in 2019 as a research associate professor at the Biomedical Research Center, where he leads the OMICS research group. His research is focused on investigating novel therapeutic targets in insulin resistance and diabetes as well as sports OMICS research. He has over 100 publications, has supervised six PhD students and a number of MSc students, and has raised more than USD 3 million in research funding.